Morrow, Jarrett D.
Castaldi, Peter J.
Chase, Robert P.
Yun, Jeong H.
Kinney, Gregory L.
Silverman, Edwin K.
Hersh, Craig P.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K25 HL136846, R01HL124233, U01HL089856, R01HL130512)
Alpha-1 Foundation (918196)
Article History
Received: 10 May 2022
Accepted: 13 January 2023
First Online: 24 January 2023
Competing interests
: Dr. Castaldi has received consulting fees and grant support from GSK. Dr. Hersh has received grant support from Bayer, Boehringer-Ingelheim, Novartis and Vertex, and Consulting fees from Astra-Zeneca and Takeda. In the past three years, Edwin K. Silverman has received grant support from GSK and Bayer. All other authors declare that they have no competing interests related to this manuscript.